Our recent observation that different apolipoproteins recruit different types of lipids on HDL and both result in distinct particle properties [6,7,8] may explain why recombinant APOA1-containing HDL particles were not found effective in treating atherosclerosis. This evidence concerns the gene APOA1 and atherosclerosis.